Connect with us

COVID-19

Trump Appointed Judge Demand FDA Release Vaccine Info This Year

“The Court concludes that this FOIA request is of paramount public importance,” the judge said.

Published

on

COVID Vaccine

A federal judge appointed by former President Donald Trump destroyed the FDA’s assessment that it would take until the year 2097 to release all of the documents pertaining to the COVID-19 vaccines.

On Thursday, U.S. District Judge Mark Pittman, who was appointed by Trump in 2019, demanded that the FDA significantly increase its speed of releasing the documents, namely saying they had to do it by the end of the year, The Blaze reported.

“The Court concludes that this FOIA request is of paramount public importance,” the judge said.

In his four-page order, he quoted James Madison who said in a letter to W.T. Barry in 1822, “A popular Government, without popular information, or the means of acquiring it, is but a Prologue to a Farce or a Tragedy; or, perhaps, both. Knowledge will forever govern ignorance: And a people who mean to be their own Governors must arm themselves with the power which knowledge gives.”

He also quoted the late President John F. Kennedy who said, “A nation that is afraid to let its people judge the truth and falsehood in an open market is a nation that is afraid of its people.”

Continue Reading
3 Comments

3 Comments

  1. Timothy Lynn Singleton

    January 8, 2022 at 10:12 am

    THIS government is TERRIFIED of the peoplw learning the truth/ 2097? They are wanting to guarantee that their crimes are seen as history and not answerable to current law enforcement bodies.

    …not that those bodies are worth a damn when it comes to equal protection under the law.

  2. Judy Chandler

    January 8, 2022 at 10:27 am

    WTH. We’ll all be dead by then. That’s the plan tho. Isn’t it

  3. liguide

    January 8, 2022 at 9:35 pm

    Thank you Judge. U.S. District Judge Mark Pittman,you are an honorable man

Leave a Reply

Your email address will not be published. Required fields are marked *

COVID-19

New data reveals NIH scientists collected $710 Million in royalties during pandemic

Published

on

GettyImages 1237662885 scaled

New data from the National Institutes of Health (NIH) reveal that the agency and its scientists collected $710 million in royalties from late 2021 through 2023. These payments, made by private companies such as pharmaceutical firms, are for licensing medical innovations developed by government scientists. A significant portion of these funds — $690 million — was directed to the National Institute of Allergy and Infectious Diseases (NIAID), led by Dr. Anthony Fauci, and its 260 scientists.

An in depth report by the New York Post reveals that the vast majority of the royalties collected during the pandemic era went to NIAID, the subagency under Dr. Fauci. The NIH has been secretive about disclosing details of this private royalty complex. OpenTheBooks.com, an organization advocating for government transparency, had to sue to uncover royalties paid from September 2009 to October 2021, which amounted to $325 million over 56,000 transactions. A second lawsuit, with Judicial Watch as counsel, was necessary to release the latest data.

During the pandemic, royalty payments to the NIH more than doubled compared to the previous twelve years combined, amounting to $1.036 billion. However, it remains unclear if royalties from COVID-19 vaccines, particularly from Pfizer and Moderna (the latter having agreed to pay $400 million to NIH), are included in these figures. The NIH has not provided clarity on this matter.

Dr. Anthony Fauci, a key figure in the U.S. COVID-19 response, is set to testify before the House Select Subcommittee on the Coronavirus Pandemic to address potential conflicts of interest and transparency issues that have plagued NIH’s handling of royalties and FOIA requests.

Fauci’s deputy, Dr. David Morens, has been implicated in using strategies to circumvent the federal Freedom of Information Act (FOIA), such as misspelling words and using physical couriers for messages. These actions have drawn significant criticism and calls for greater transparency.

Senator Rand Paul (R-Ky.) has sponsored the Royalty Transparency Act, which has unanimously passed the committee stage and is awaiting a floor vote. This act aims to provide greater transparency regarding royalty payments to government scientists.

 

Continue Reading

Trending